Granules Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GRANULES, and what generic and branded alternatives to GRANULES drugs are available?
GRANULES has sixty-three approved drugs.
There is one tentative approval on GRANULES drugs.
Summary for Granules
US Patents: | 0 |
Tradenames: | 49 |
Ingredients: | 49 |
NDAs: | 63 |
Patent Litigation for Granules: | See patent lawsuits for Granules |
Drugs and US Patents for Granules
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Granules | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; losartan potassium | TABLET;ORAL | 218015-002 | Sep 29, 2023 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Granules | POTASSIUM CHLORIDE | potassium chloride | SOLUTION;ORAL | 213392-002 | Jan 29, 2021 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Granules | ESOMEPRAZOLE MAGNESIUM | esomeprazole magnesium | CAPSULE, DELAYED REL PELLETS;ORAL | 217427-002 | Oct 18, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Granules | DOFETILIDE | dofetilide | CAPSULE;ORAL | 212750-003 | Oct 14, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Granules | NAPROXEN | naproxen | TABLET;ORAL | 074140-002 | Dec 21, 1993 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.